1. Home
  2. PHR vs BBNX Comparison

PHR vs BBNX Comparison

Compare PHR & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHR
  • BBNX
  • Stock Information
  • Founded
  • PHR 2005
  • BBNX 2015
  • Country
  • PHR United States
  • BBNX United States
  • Employees
  • PHR N/A
  • BBNX N/A
  • Industry
  • PHR Business Services
  • BBNX Medical/Dental Instruments
  • Sector
  • PHR Consumer Discretionary
  • BBNX Health Care
  • Exchange
  • PHR Nasdaq
  • BBNX Nasdaq
  • Market Cap
  • PHR 1.3B
  • BBNX 1.2B
  • IPO Year
  • PHR 2019
  • BBNX 2025
  • Fundamental
  • Price
  • PHR $20.36
  • BBNX $31.52
  • Analyst Decision
  • PHR Strong Buy
  • BBNX Strong Buy
  • Analyst Count
  • PHR 15
  • BBNX 11
  • Target Price
  • PHR $33.73
  • BBNX $28.09
  • AVG Volume (30 Days)
  • PHR 650.8K
  • BBNX 723.4K
  • Earning Date
  • PHR 12-08-2025
  • BBNX 10-28-2025
  • Dividend Yield
  • PHR N/A
  • BBNX N/A
  • EPS Growth
  • PHR N/A
  • BBNX N/A
  • EPS
  • PHR N/A
  • BBNX N/A
  • Revenue
  • PHR $449,672,000.00
  • BBNX $88,570,000.00
  • Revenue This Year
  • PHR $14.77
  • BBNX $52.13
  • Revenue Next Year
  • PHR $11.68
  • BBNX $36.07
  • P/E Ratio
  • PHR N/A
  • BBNX N/A
  • Revenue Growth
  • PHR 15.31
  • BBNX 67.01
  • 52 Week Low
  • PHR $18.20
  • BBNX $8.89
  • 52 Week High
  • PHR $32.76
  • BBNX $32.11
  • Technical
  • Relative Strength Index (RSI)
  • PHR 37.66
  • BBNX 69.61
  • Support Level
  • PHR $18.91
  • BBNX $26.13
  • Resistance Level
  • PHR $20.56
  • BBNX $29.22
  • Average True Range (ATR)
  • PHR 0.88
  • BBNX 2.04
  • MACD
  • PHR -0.21
  • BBNX 0.26
  • Stochastic Oscillator
  • PHR 38.07
  • BBNX 85.27

About PHR Phreesia Inc.

Phreesia Inc is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations by activating patients in their care to optimize patient health outcomes. Through its SaaS-based technology platform, it offers healthcare services clients a robust suite of integrated solutions that manage patient access, registration, payments, and clinical support. The Phreesia Platform encompasses a comprehensive range of technologies and services, including, initial patient contact, registration, automated answering services, appointment scheduling, payments, and post-appointment patient surveys.

About BBNX Beta Bionics Inc. Common Stock

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.

Share on Social Networks: